lomustine has been researched along with methylprednisolone in 23 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 9 (39.13) | 18.7374 |
1990's | 5 (21.74) | 18.2507 |
2000's | 3 (13.04) | 29.6817 |
2010's | 6 (26.09) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Cooper, MR; Muss, HB; Richards, F; Spurr, CL; White, DR | 1 |
Campbell, RJ; Laws, ER; Saez, RJ | 1 |
Byrd, A; Finn, A; Levin, VA; Stearns, J; Weinkam, RJ | 1 |
Ahrenberg, P; Ala-Harja, K; Almqvist, A; Hänninen, A; Ilvonen, M; Isomaa, B; Järvenpää, E; Jouppila, J; Kilpi, H; Palva, IP | 1 |
Bleyer, WA; Geyer, JR; Heideman, RL; Kosnik, EJ; Milstein, JM; Morris, JD; Mulne, AF; Pendergrass, TW; Ruymann, FB; Stuntz, JT | 1 |
Brunat-Mentigny, M; Chastagner, P; Czorny, A; Lapras, C; Olive, D; Philip, T; Zucker, JM | 1 |
Ahrenberg, P; Ala-Harja, K; Almqvist, A; Apajalahti, J; Hallman, H; Hänninen, A; Ilvonen, M; Isomaa, B; Järvenpää, E; Palva, IP | 1 |
Holománová, D; Lipsic, T; Mikulecký, M; Mistrík, M; Sakalová, A; Steruská, M | 1 |
Ala-Harja, K; Almqvist, A; Elonen, E; Hallman, H; Hänninen, A; Ilvonen, M; Isomaa, B; Järvenpää, E; Jouppila, J; Palva, IP | 1 |
Ilveskoski, I; Lanning, M; Mäkipernaa, A; Perkkiö, M; Pihko, H; Saarinen, UM; Salmi, TT; Wiklund, T | 1 |
Akimov, MA; Gershanovich, ML | 1 |
Bock, PR; Chabronová, I; Dedík, L; Gazová, S; Hanisch, J; Holomanova, D; Hrubisko, M; Mistrík, M; Sakalová, A; Schiess, W | 1 |
Baron, B; Bogdhan, U; Chinot, O; De Beule, N; Delattre, JY; Frenay, M; Hildebrand, J; Hoang-Xuan, K; Soubeyran, P; Taillandier, L | 1 |
Choquet, S; Elhallani, S; Gonzalez-Aguilar, A; Hoang-Xuan, K; Houillier, C; Idbaih, A; Kaloshi, G; Navarro, S; Omuro, A; Ricard, D; Sierra Del Rio, M; Soussain, C | 1 |
Guo, J; Parasramka, S; Rosenfeld, M; Talari, G; Villano, JL | 1 |
2 review(s) available for lomustine and methylprednisolone
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Procarbazine, lomustine and vincristine for recurrent high-grade glioma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cytarabine; Dacarbazine; Disease Progression; Disease-Free Survival; Drug Administration Schedule; Glioma; Humans; Hydroxyurea; Lomustine; Methylprednisolone; Middle Aged; Neoplasm Recurrence, Local; Procarbazine; Randomized Controlled Trials as Topic; Temozolomide; Vincristine | 2017 |
8 trial(s) available for lomustine and methylprednisolone
Article | Year |
---|---|
CCNU, bleomycin, and methylprednisolone with or without adriamycin in renal cel carcinoma: a randomized trial.
Topics: Adenocarcinoma; Antineoplastic Agents; Bleomycin; Doxorubicin; Drug Therapy, Combination; Female; Humans; Lomustine; Male; Methylprednisolone; Middle Aged; Neoplasm Metastasis | 1977 |
Combination chemotherapy MOCCA in resistant and relapsing multiple myeloma. Finnish Leukaemia Group.
Topics: Aged; Alkylating Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Drug Resistance; Follow-Up Studies; Humans; Immunoglobulin A; Immunoglobulin G; Immunoglobulin Light Chains; Lomustine; Melphalan; Methylprednisolone; Middle Aged; Multiple Myeloma; Neoplasm Staging; Recurrence; Treatment Outcome; Vincristine | 1992 |
Treatment of multiple myeloma in old patients. Finnish Leukaemia Group.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Humans; Lomustine; Melphalan; Methylprednisolone; Multiple Myeloma; Vincristine | 1989 |
Treatment of multiple myeloma with an intensive 5-drug combination or intermittent melphalan and prednisone; a randomised multicentre trial. Finnish Leukaemia Group.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Drug Administration Schedule; Female; Humans; Immunoglobulins; Lomustine; Male; Melphalan; Methylprednisolone; Middle Aged; Multiple Myeloma; Prednisone; Vincristine | 1987 |
Aggressive combination chemotherapy in multiple myeloma. A multicentre trial. Finnish Leukaemia Group.
Topics: Adult; Aged; Clinical Trials as Topic; Cyclophosphamide; Female; Humans; Lomustine; Male; Melphalan; Methylprednisolone; Middle Aged; Multiple Myeloma; Prognosis; Vincristine | 1985 |
Corticosteroid is not beneficial in multiple-drug combination chemotherapy for multiple myeloma. Finnish Leukaemia Group.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Female; Humans; Leukemia, Myeloid, Acute; Lomustine; Male; Melphalan; Methylprednisolone; Middle Aged; Multiple Myeloma; Myelodysplastic Syndromes; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Survival Rate; Vincristine | 1993 |
Ototoxicity in children with malignant brain tumors treated with the "8 in 1" chemotherapy protocol.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dacarbazine; Drug Administration Schedule; Evaluation Studies as Topic; Female; Follow-Up Studies; Hearing Loss; Humans; Hydroxyurea; Incidence; Infant; Lomustine; Male; Methylprednisolone; Procarbazine; Radiation Injuries; Risk Factors; Vincristine | 1996 |
Chemotherapy alone as initial treatment for primary CNS lymphoma in patients older than 60 years: a multicenter phase II study (26952) of the European Organization for Research and Treatment of Cancer Brain Tumor Group.
Topics: Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Belgium; Biopsy, Needle; Central Nervous System Neoplasms; Cytarabine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Injections, Spinal; Lomustine; Lymphoma; Male; Methotrexate; Methylprednisolone; Middle Aged; Multivariate Analysis; Neoplasm Staging; Probability; Procarbazine; Research; Risk Assessment; Survival Analysis; Treatment Outcome | 2003 |
13 other study(ies) available for lomustine and methylprednisolone
Article | Year |
---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Chemotherapeutic trials on human malignant astrocytomas in organ culture.
Topics: Antineoplastic Agents; Astrocytoma; Carmustine; Cell Survival; Cyanides; Drug Evaluation, Preclinical; Etoposide; Humans; Lomustine; Luciferases; Methylprednisolone; NAD; Organ Culture Techniques | 1977 |
The effect of phenobarbital pretreatment on the antitumor activity of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU), 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) and 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl-1-nitrosourea (PCNU), and on the plasma p
Topics: Alkylating Agents; Animals; Biotransformation; Brain Neoplasms; Carmustine; Dexamethasone; Drug Interactions; In Vitro Techniques; Kinetics; Liver; Lomustine; Male; Methylprednisolone; Neoplasms, Experimental; Nitrosourea Compounds; Phenobarbital; Phenytoin; Rats; Rats, Inbred F344 | 1979 |
Improved long-term survival in multiple myeloma. Finnish Leukaemia Group.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Finland; Humans; Lomustine; Melphalan; Methylprednisolone; Multiple Myeloma; Prognosis; Remission Induction; Survival Analysis; Time Factors; Vincristine | 1989 |
Eight drugs in one day chemotherapy for brain tumors: experience in 107 children and rationale for preradiation chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Child; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dacarbazine; Drug Evaluation; Glioblastoma; Humans; Hydroxyurea; Lomustine; Medulloblastoma; Methylprednisolone; Neoplasm Recurrence, Local; Procarbazine; Vincristine | 1987 |
[Efficacy of the "8 drugs in a day" protocol in brain tumors in children].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Cerebellar Neoplasms; Child; Child, Preschool; Cytarabine; Cytidine Diphosphate Diglycerides; Dacarbazine; Female; Glioma; Humans; Hydroxyurea; Infant; Lomustine; Male; Medulloblastoma; Methylprednisolone; Procarbazine; Vincristine | 1988 |
Prognostic value of plasma-cell immunophenotype in patients with multiple myeloma.
Topics: Adult; Aged; Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Female; HLA-DR Antigens; Humans; Immunoglobulin A; Immunoglobulin G; Immunoglobulin Isotypes; Immunophenotyping; Lomustine; Longitudinal Studies; Male; Melphalan; Methylprednisolone; Middle Aged; Multiple Myeloma; Plasma Cells; Prednisone; Prognosis; Regression Analysis; Survival Analysis; Vincristine | 1993 |
[Evaluation of the CCNU-COP regimen for primary refractory and recurrent non-Hodgkin's lymphoma].
Topics: Adult; Aged; Anemia; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Female; Humans; Hydrocortisone; Leukopenia; Lomustine; Lymphoma, Non-Hodgkin; Male; Methotrexate; Methylprednisolone; Middle Aged; Treatment Outcome; Vincristine | 1999 |
Retrolective cohort study of an additive therapy with an oral enzyme preparation in patients with multiple myeloma.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chymotrypsin; Cohort Studies; Cyclophosphamide; Dexamethasone; Doxorubicin; Drug Combinations; Endopeptidases; Female; Humans; Lomustine; Male; Melphalan; Methylprednisolone; Middle Aged; Multiple Myeloma; Papain; Prednisone; Proportional Hazards Models; Retrospective Studies; Survival Rate; Trypsin; Vincristine | 2001 |
Prophylactic intrathecal chemotherapy in primary CNS lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cohort Studies; Disease-Free Survival; Female; Follow-Up Studies; Humans; Injections, Spinal; Karnofsky Performance Status; Lomustine; Lymphoma; Male; Methotrexate; Methylprednisolone; Middle Aged; Neoplasm Recurrence, Local; Neuroprotective Agents; Procarbazine; Retrospective Studies; Young Adult | 2012 |